Skip to Content
Merck
CN
  • Human trabecular meshwork sphingolipid and ceramide profiles and potential latent fungal commensalism.

Human trabecular meshwork sphingolipid and ceramide profiles and potential latent fungal commensalism.

Investigative ophthalmology & visual science (2014-05-03)
Ayman J Aljohani, Genea Edwards, Yenifer Guerra, Sander Dubovy, Darlene Miller, Richard K Lee, Sanjoy K Bhattacharya
ABSTRACT

We determined the profiles of sphingomyelin, sphingoid base, sphingoid base-1-phosphate, and ceramide, and their quantitative differences between control and glaucomatous trabecular meshwork (TM) derived from human donors. Control and primary open angle glaucoma (POAG) TM samples were collected from cadaver donors. In addition, POAG TM surgical specimens also were procured. Lipid extraction was performed using suitable modifications of the Bligh and Dyer method. Protein concentrations were determined using Bradford's method. Lipids, identified using standardized class-specific lipid mass spectrometry, were quantified using a two-step ratiometric process. Gomori methenamine silver (GMS) staining was performed for detection of presence of Fusarium in the anterior eye tissue sections. PCR analyses were performed for detection of Fusarium species in the donor TM samples. Several species of sphingomyelin, sphingoid base, sphingoid base-1-phosphate, and ceramide were common between control and POAG TM. Only a subset of species in some of these classes were identified uniquely either in controls or in POAG TM. Several lipid species of fungal origin (many from Fungi imperfecti, Fusarium species) were found to be common between control and POAG TM. The GMS staining and PCR analyses showed presence of DNA belonging to Fusarium species suggesting latent commensalism. Most sphingolipids and ceramides (except a few unique to a specific donor TM group) were found to be common in the control and POAG TM. Latent commensalism by Fusarium was suggested by identification of Fusarium-specific lipids, which was supported further by PCR amplification and sequencing of DNA.

MATERIALS
Product Number
Brand
Product Description

Avanti
C18:1 Ceramide (d18:1/18:1(9Z)), Avanti Polar Lipids 860519P, powder
Avanti
18:1 SM (d18:1/18:1(9Z)), Avanti Polar Lipids 860587P, powder